Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 209

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 6
Chunk 209
---
. Milch has been a self-employed independent investor in the life sciences
and technology areas for the past 30 years. Recently, Dr. Milch pursued a number of media opportunities, as the lead investor, including
Mila-Media, BeTerrific! and others. In 2014, Dr. Milch invested in the first biopharma spinout from well-known genomics research leader
Jackson Laboratories, Cyteir Therapeutics, with co-investors Celgene Corporation, Venrock, Silverlake and others. In 2010, Dr. Milch established
the Dr. David M. Milch Foundation to serve “ Tikkun Olam” (healing the world) in two primary areas: Arts for Social Impact
which focuses on film, theater, and other modes of creativity, and Youth Mentoring, which helps foster leadership development and civic
responsibility. In 2008, Dr. Milch was part of the small angel group which capitalized Games24X7 in India, currently named RummyCircle.
Dr. Milch received his B. S. in Biology at Stanford University and his M. D. from Harvard Medical School. We believe that Dr. Milch’s
financial and industry experience qualify him to serve on our board of directors.

There are no family relationships
among any of our executive officers or directors.

There are no arrangements
or understandings with major shareholders, customers, suppliers or others, pursuant to which any person referred to above was selected
as a director or member of senior management.

  Compensation  
 ────────────────

Directors

Under the Companies Law, the
compensation of a public company’s directors requires the approval of (i) its compensation committee, (ii) its board of directors
and, unless exempted under regulations promulgated under the Companies Law, (iii) the approval of its shareholders at a general meeting.
In addition, if the compensation of a public company’s directors is inconsistent with the company’s compensation policy, then
those inconsistent provisions must be separately considered by the compensation committee and board of directors, and approved by the
shareholders by a special vote in one of the following two ways:

  at least a majority of the                                                                                                            

  the total number of shares                                                                                                                      

None of our directors have entered, or proposes
to enter, into service agreements with us which provide for benefits upon termination of employment.

Executive officers other than the chief
executive officer

The Companies Law requires
the